APG-2575

· Ascentage Pharma Group Inc.

Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for APG-2575, covering 2023-03-07 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL [Phase 2]